Matthew G. Gipson

Mice Deficient in Complement Receptors 1 and 2 Lack a Tissue Injury-Inducing Subset of the Natural Antibody Repertoire

Sherry D. Fleming, Terez Shea‐Donohue, Joel M. Guthridge et al. · The Journal of Immunology · 2002 · 177 citations

Life Sciences, Immunology, Pathology +14

Structural Studies in Solution of the Recombinant N-Terminal Pair of Short Consensus/Complement Repeat Domains of Complement Receptor Type 2 (CR2/CD21) and Interactions with Its Ligand C3dg

Joel M. Guthridge, Jonathan K. Rakstang, Kendra A. Young et al. · Biochemistry · 2001 · 61 citations

Life Sciences, Immunology, Molecular Biology +16

Bronchial Atresia

Matthew G. Gipson, Kristopher W. Cummings, Kyle Hurth · Radiographics · 2009 · 59 citations

Epitope Mapping Using the X-Ray Crystallographic Structure of Complement Receptor Type 2 (CR2)/CD21: Identification of a Highly Inhibitory Monoclonal Antibody That Directly Recognizes the CR2-C3d Interface

Joel M. Guthridge, Kendra A. Young, Matthew G. Gipson et al. · The Journal of Immunology · 2001 · 54 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

Intravascular US–Guided Portal Vein Access: Improved Procedural Metrics during TIPS Creation

Matthew G. Gipson, Mitchell Smith, Janette D. Durham et al. · Journal of Vascular and Interventional Radiology · 2016 · 51 citations

Medicine, Surgery, Interventional Radiology +13